Rapid Polymerase Chain Reaction Assay to Detect Variation in the Extent of Gene‐specific Damage between Cisplatin‐ or VP‐16‐resistant and Sensitive Lung Cancer Cell Lines

od Oshita, Fumihiro, Saijo, Nagahiro
izdano v Jpn J Cancer Res (1994)

Correlation of Gene‐specific Damage with Cisplatin between Human Adenocarcinoma Cells and Peripheral Blood Mononuclear Cells Analyzed by Polymerase Chain Reaction‐stop Assay

od Oshita, Fumihiro, Arioka, Hitoshi, Heike, Yuji, Shiraishi, Jun‐ichi, Saijo, Nagahiro
izdano v Jpn J Cancer Res (1995)

Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy

od HARADA, TAISHI, SAITO, HARUHIRO, KARINO, FUMI, ISAKA, TETSUYA, MURAKAMI, SHUJI, KONDO, TETSURO, OSHITA, FUMIHIRO, MIYAGI, YOHEI, YAMADA, KOUZO
Izdano 2014

Prospective Evaluation of the Feasibility of Cisplatin‐based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions

od Oshita, Fumihiro, Kurata, Takayasu, Kasai, Takashi, Fukuda, Minoru, Yamamoto, Nobuyuki, Ohe, Yuichiro, Tamura, Tomohide, Eguchi, Kenji, Shinkai, Tetsu, Saijo, Nagahiro
izdano v Jpn J Cancer Res (1995)

Subcutaneous Administration of Recombinant Human Granulocyte Colony‐stimulating Factor (KRN8601) in Intensive Chemotherapy for Patients with Advanced Lung Cancer

od Eguchi, Kenji, Shinkai, Tetsu, Sasaki, Yasutsuna, Tamura, Tomohide, Ohe, Yuichiro, Nakagawa, Kazuhiko, Fukuda, Masaaki, Yamada, Kouzou, Kojima, Akira, Oshita, Fumihiro, Morita, Masashige, Suemasu, Keiichi, Saijo, Nagahiro
izdano v Jpn J Cancer Res (1990)

CPT‐11: Population Pharmacokinetic Model and Estimation of Pharmacokinetics Using the Bayesian Method in Patients with Lung Cancer

od Yamamoto, Nobuyuki, Tamura, Tomohide, Karato, Atsuya, Uenaka, Kazunori, Eguchi, Kenji, Shinkai, Tetsu, Ohe, Yuichiro, Oshita, Fumihiro, Arioka, Hitoshi, Nakashima, Hajime, Shiraishi, Jun‐ichi, Fukuda, Minoru, Higuchi, Shun, Saijo, Nagahiro
izdano v Jpn J Cancer Res (1994)

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

od Nishii, Teppei, Yokose, Tomoyuki, Miyagi, Yohei, Daigo, Yataro, Ito, Hiroyuki, Isaka, Tetsuya, Imai, Kentaro, Murakami, Shuji, Kondo, Tetsuro, Saito, Haruhiro, Oshita, Fumihiro, Yamada, Kouzo, Matsukuma, Shoichi, Tsuboi, Masahiro, Nakayama, Haruhiko, Masuda, Munetaka
Izdano 2014

Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014

od Takagi, Yusuke, Hosomi, Yukio, Oshita, Fumihiro, Okamoto, Hiroaki, Seki, Nobuhiko, Minato, Koichi, Aono, Hiromi, Yamada, Kouzo, Okuma, Yusuke, Hida, Naoya, Sakamoto, Takahiko, Miura, Yosuke, Yomota, Makiko, Satoh, Akira, Kunitoh, Hideo, Sakamaki, Kentaro, Shibuya, Masahiko, Watanabe, Koshiro
izdano v BMC Cancer (2015)

Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection

od Miyagi, Yohei, Higashiyama, Masahiko, Gochi, Akira, Akaike, Makoto, Ishikawa, Takashi, Miura, Takeshi, Saruki, Nobuhiro, Bando, Etsuro, Kimura, Hideki, Imamura, Fumio, Moriyama, Masatoshi, Ikeda, Ichiro, Chiba, Akihiko, Oshita, Fumihiro, Imaizumi, Akira, Yamamoto, Hiroshi, Miyano, Hiroshi, Horimoto, Katsuhisa, Tochikubo, Osamu, Mitsushima, Toru, Yamakado, Minoru, Okamoto, Naoyuki
Izdano 2011